REVIEW SERIES
Exacerbations in cystic fibrosis: 3 · Management
1 Department of Child Health, University of Nottingham and Department of Paediatric Respiratory Medicine, Nottingham City Hospital, Nottingham, UK
2 Department of Respiratory Medicine, Queens University and Belfast City Hospital, Belfast, UK
Correspondence to:
Professor J S Elborn, Adult Cystic Fibrosis Centre, Level 11, Belfast City Hospital, Belfast BT9 7AB, UK; stuart.elborn{at}bch.n-i.nhs.uk
Exacerbations of pulmonary symptoms in patients with cystic fibrosis must be recognised early and treated vigorously in order to maintain pulmonary function and relieve symptoms. The aetiology of these exacerbations is discussed, together with the options for treatment and the evidence to support treatment choices.
This article has been cited by other articles:
-
Goubau, C, Wilschanski, M, Skalicka, V, Lebecque, P, Southern, K W, Sermet, I, Munck, A, Derichs, N, Middleton, P G, Hjelte, L, Padoan, R, Vasar, M, De Boeck, K
(2009). Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Thorax
64: 683-691
[Abstract] [Full Text] -
Wedzicha, J. A, Johnston, S. L
(2008). Thorax update: October 2007-September 2008. Thorax
63: 1036-1037
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
